Assoc. Prof. Dr. Jilong Wang | Material Science | Best Researcher Award
Associate Professor of Wenzhou Institute of Science and Technology, China
Dr. Jilong Wang π¨βπ¬ is an Associate Professor at the Wenzhou Institute, University of Chinese Academy of Sciences, in Wenzhou, China π¨π³. With a Ph.D. from the School of Life Sciences at the University of Science and Technology of China (USTC) and a B.S. in Biomedical Engineering from Tianjin Medical University, Dr. Wang has a robust background in biomedical sciences π. He completed his postdoctoral research at the South China University of Technology (SCUT), focusing on biodegradable nanomaterial-based drug delivery systems. His research aims to develop innovative therapies for malignant, infectious, and immune-related diseases, emphasizing tumor vaccine immunotherapy, cancer stem cell-targeted therapy, and anti-infective treatments π.
Professional profile
Educationπ
Dr. Jilong Wang’s educational journey π¨βπ is marked by significant achievements and dedication to the field of biomedical sciences. He earned his Ph.D. from the School of Life Sciences at the University of Science and Technology of China (USTC) in 2018 π. Prior to that, he completed his B.S. in Biomedical Engineering at Tianjin Medical University in 2013 π. During his postdoctoral research fellowship at the School of Biomedical Sciences and Engineering, South China University of Technology (SCUT) from 2018 to 2020 π§ͺ, he further honed his expertise in biodegradable nanomaterial-based drug delivery systems. Dr. Wang’s academic background has laid a solid foundation for his pioneering research in targeted therapies for malignant, infectious, and immune-related diseases π.
Professional ExperienceποΈ
Dr. Jilong Wang’s professional experience spans significant roles in prestigious institutions ποΈ. Since April 2020, he has been serving as an Associate Professor at the Wenzhou Institute, University of Chinese Academy of Sciences π§βπ«. Prior to this, he was a Postdoctoral Research Fellow at the School of Biomedical Sciences and Engineering, South China University of Technology (SCUT) from June 2018 to April 2020 π¬. Dr. Wang’s professional journey is characterized by his commitment to advancing research in biodegradable nanomaterial-based drug delivery systems, with a focus on developing targeted therapies for malignant, infectious, and immune-related diseases π§ͺ. His roles have enabled him to contribute significantly to the field, driving innovation and research excellence π.
Research Interestπ
Dr. Jilong Wang’s research interests are centered around developing innovative biodegradable nanomaterial-based drug delivery systems π―. His work primarily focuses on targeted therapies for malignant, infectious, and immune-related diseases. He is particularly interested in tumor vaccine immunotherapy, cancer stem cell (CSC)-targeted therapy, and anti-infective therapy π. Dr. Wang aims to design nanoparticle systems for drug delivery to tumor-associated cells and tumor-initiating cells by leveraging their sensitivity to tumor microenvironments π¦ . Additionally, he explores intelligent polymeric nanoparticles for differential drug delivery and novel degradable polymers as nanomedicines for biomedical applications π. His research is driven by the goal of creating effective and precise treatments for complex diseases, enhancing the efficacy and safety of therapeutic interventions π.
Awards and Honorsπ
Dr. Jilong Wang has been recognized for his significant contributions to biomedical research with several prestigious awards and honors π. He received the General Project of China Postdoctoral Science Foundation (2018.11-2020.05) π, and the General Project of Natural Science Foundation of Guangdong Province (2019.10-2022.09) π. His innovative work also earned him the Wenzhou Basic Scientific Research Project grant (2020.07-2021.12) π and the Major Project of Wenzhou Research Institute, University of Chinese Academy of Sciences (2020.10-2023.03) π₯. Furthermore, Dr. Wang was honored with funding from the Zhejiang Key Laboratory of New Techniques for Diagnosis and Treatment of Pancreatic and Liver Critical Diseases
Research skillπ¬
Dr. Jilong Wang possesses a robust set of research skills that make him a leading figure in the field of biomedical engineering π§ͺ. He is highly proficient in developing biodegradable nanomaterial-based drug delivery systems π―, specifically designed for targeted therapies against malignant, infectious, and immune-related diseases π§¬. His expertise extends to creating nanoparticle systems for drug delivery to tumor-associated cells and tumor-initiating cells, with a focus on their sensitivity to tumor microenvironments π¬. Dr. Wang is also adept at designing intelligent polymeric nanoparticles for differential drug delivery π¦, and innovating novel degradable polymers as nanomedicines for various biomedical applications π. His technical skills are complemented by his ability to secure significant research funding and collaborate on major projects, demonstrating his leadership and impact in advancing medical science π.
Achievementsπ
- Secured the General Project of China Postdoctoral Science Foundation (2018.11-2020.05) ππ
- Awarded the General Project of Natural Science Foundation of Guangdong Province (2019.10-2022.09) ππ
- Received funding for the Wenzhou Basic Scientific Research Project (2020.07-2021.12) π¬π‘
- Led the Major Project of Wenzhou Research Institute, University of Chinese Academy of Sciences (2020.10-2023.03) πποΈ
- Contributed to the Zhejiang Key Laboratory of New Techniques for Diagnosis and Treatment of Pancreatic and Liver Critical Diseases, Open Foundation (2021.01-2023.12) π§ͺπ
- Acquired the prestigious National Natural Science Foundation of China grant (2022.01-2024.12) π π¨π³
Projectsπ
- General Project of China Postdoctoral Science Foundation (2018.11-2020.05) ππ
- Focus: Developing innovative biomedical solutions π¬π‘
- General Project of Natural Science Foundation of Guangdong Province (2019.10-2022.09) ππ
- Focus: Advanced research in biomedical engineering and drug delivery systems π§ͺπ
- Wenzhou Basic Scientific Research Project (2020.07-2021.12) π¬π‘
- Focus: Foundational research in novel biomedical applications π±π
- Major Project of Wenzhou Research Institute, University of Chinese Academy of Sciences (2020.10-2023.03) πποΈ
- Focus: Cutting-edge research in nanomedicine and targeted therapies πβ¨
- Zhejiang Key Laboratory of New Techniques for Diagnosis and Treatment of Pancreatic and Liver Critical Diseases, Open Foundation (2021.01-2023.12) π§ͺπ
- Focus: Innovative diagnostic and treatment techniques for critical diseases π©Ίπ¬
- National Natural Science Foundation of China (2022.01-2024.12) π
π¨π³
- Focus: Pioneering research in biodegradable nanomaterials for drug delivery systems ππ
Publicationsπ
- Ji-Long Wang, Yun-Ju Gan, Shoailb Iqbal, Wei Jiang, You-Yong Yuan, Jun Wang
Title: Delivery of tacrolimus with cationic lipid-assisted nanoparticles for ulcerative colitis therapy
Journal: Biomaterials Science, 2018
Citation: 6, 1916-1922
πππ¬ - Ji-Long Wang, Xiao-Jiao Du, Jin-Xian Yang, Song Shen, Hong-Jun Li, Ying-Li Luo, Shoailb Iqbal, Cong-Fei Xu, Xiao-Dong Ye, Jie Cao, Jun Wang
Title: The effect of surface poly(ethylene glycol) length on in vivo drug delivery behaviors of polymeric nanoparticles
Journal: Biomaterials, 2018
Citation: 182, 104-113
ππ§ͺ𧬠- Xiao-Jiao Du, Ji-Long Wang, Shoailb Iqbal, Hong-Jun Li, Zhi-Ting Cao, Yu-Cai Wang, Jin-Zhi Du, Jun Wang
Title: The effect of surface charge on oral absorption of polymeric nanoparticles
Journal: Biomaterials Science, 2018
Citation: 6, 642-650
ππ§ͺπ - Wei Jiang, Ji-Long Wang, Jin-Bin Yang, Zhi-Wei He, Zhen-Hui Hou, Ying-Li Luo, Li Wang, Yang-Yang Zhao, Xue-Chang Zhou, Li-Feng Yan, Xian-Zhu Yang, Yu-Cai Wang, Jun Wang
Title: Acidity-triggered TAT-presenting nanocarriers augment tumor retention and nuclear translocation of drugs
Journal: Nano Research, 2017
Citation: 11, 1-19
ππ§¬π¬ - Chun-Guang Dai, Ji-Long Wang, Ying-Long Fu, Hong-Ping Zhou, Qin-Hua Song
Title: Selective and real-time detection of nitric oxide by a two-photon fluorescent probe in live cells and tissue slices
Journal: Analytical Chemistry, 2017
Citation: 19, 10511-10519
ππ¬π‘ - Shoailb Iqbal, Xiao-Jiao Du, Ji-Long Wang, Hong-Jun Li, You-Yong Yuan, Jun Wang
Title: Surface charge tunable nanoparticles for TNF-Ξ± siRNA oral delivery for treating ulcerative colitis
Journal: Nano Research, 2017
Citation: 11, 1998-0124
πππ§ͺ - Chun-Guang Dai, Ji-Long Wang, Qin-Hua Song
Title: Red fluorescent probes based on a bodipy analogue for selective and sensitive detection of selenols in solutions and in living systems
Journal: Journal of Materials Chemistry B, 2016
Citation: 4, 6726-6733
ππ§¬π¬ - Xiao-Jiao Du, Ji-Long Wang (co-first author), Wei-Wei Liu, Jin-Xian Yang, Chun-Yang Sun, Rong Sun, Hong-Jun Li, Song Shen, Ying-Li Luo, Xiao-Dong Ye, Xian-Zhu Yang, Jun Wang
Title: Regulating the surface poly(ethylene glycol) density of polymeric nanoparticles and evaluating its role in drug delivery in vivo
Journal: Biomaterials, 2015
Citation: 69, 1-11
πππ§ͺ